Stuart grew up in Belfast, Northern Ireland, and qualified in Physiology from Cambridge, Medicine from Oxford, and a PhD from Newcastle University, where his thesis explored genetic and epigenetic determinants of macrophage function in liver disease. His specialty training was in Internal Medicine, Gastroenterology and Hepatology in Nottingham, London and Newcastle upon Tyne.
He joined GSK R&D in 2014. After roles in discovery research and clinical development, he now leads Medical for Hepatology which includes programs in chronic hepatitis B virus infection, cholestatic liver disease and NASH fibrosis.
Stuart holds a GSK Senior Fellowship and chairs GSK’s Hepatic Safety Panel. He is an honorary consultant hepatologist at Cambridge University Hospitals where he sees patients on Friday mornings.
